1
|
Bentzer P, Russell JA and Walley KR:
Advances in sepsis research. Clin Chest Med. 36:521–530. 2015.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Guidelines for treatment of severe
sepsis/septic shock in China. Crit Care Med. 6:401–426. 2015.(In
Chinese).
|
3
|
Kübler A, Adamik B, Ciszewicz-Adamiczka B
and Ostrowska E: Severe sepsis in intensive care units in Poland -
a point prevalence study in 2012 and 2013. Anaesthesiol Intensive
Ther. 47:315–319. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhang D, Li H and Li J: The change of
cardiac troponin I on patients with sepsis and septic shock as well
as its clinical significance. J Pract Med. 27:49–51. 2011.
|
5
|
Wang X, Wei S and Li T: The application of
coagulation-fibrinolysis dynamic graph on the detection of sepsis
coagulation fibrinolytic imbalances. Chongqing Med J. 37:1706–1708.
2008.
|
6
|
Altintas Z, Fakanya WM and Tothill IE:
Cardiovascular disease detection using bio-sensing techniques.
Talanta. 128:177–186. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Jiang Z and Ye GY: 1:4 matched
case-control study on influential factor of early onset neonatal
sepsis. Eur Rev Med Pharmacol Sci. 17:2460–2466. 2013.PubMed/NCBI
|
8
|
Mahmoudi L, Mohammadpour AH, Ahmadi A,
Niknam R and Mojtahedzadeh M: Influence of sepsis on higher daily
dose of amikacin pharmacokinetics in critically ill patients. Eur
Rev Med Pharmacol Sci. 17:285–291. 2013.PubMed/NCBI
|
9
|
Liu YJ, Du P and Rao J: Procalcitonin as a
diagnostic and prognostic marker for sepsis caused by intestinal
infection: a case report. Eur Rev Med Pharmacol Sci. 17:1311–1313.
2013.PubMed/NCBI
|
10
|
Levy MM, Fink MP, Marshall JC, Abraham E,
Angus D, Cook D, Cohen J, Opal SM, Vincent JL and Ramsay G:
International Sepsis Definitions Conference: 2001
SCCM/ESICM/ACCP/ATS/S1S International Sepsis Definition Conference.
Intensive Care Med. 29:530–538. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Jozwiak M, Persichini R, Monnet X and
Teboul JL: Management of myocardial dysfunction in severe sepsis.
Semin Respir Crit Care Med. 32:206–214. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Pulido JN, Afessa B, Masaki M, Yuasa T,
Gillespie S, Herasevich V, Brown DR and Oh JK: Clinical spectrum,
frequency, and significance of myocardial dysfunction in severe
sepsis and septic shock. Mayo Clin Proc. 87:620–628. 2012.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang XH, Dong Y, Chen YD, Zhou P, Wang JD
and Wen FQ: Serum N-terminal pro-brain natriuretic peptide level is
a significant prognostic factor in patients with severe sepsis
among Southwest Chinese population. Eur Rev Med Pharmacol Sci.
17:517–521. 2013.PubMed/NCBI
|
14
|
Celik IH, Demirel G, Oguz SS, Uras N,
Erdeve O and Dilmen U: Compassionate use of voriconazole in newborn
infants diagnosed with severe invasive fungal sepsis. Eur Rev Med
Pharmacol Sci. 17:729–734. 2013.PubMed/NCBI
|
15
|
Shen ZG, Guo JL and Li DS: Screening of
differentially expressed genes related to severe sepsis induced by
multiple trauma with DNA microarray. Eur Rev Med Pharmacol Sci.
18:734–739. 2014.PubMed/NCBI
|
16
|
Werdan K, Schmidt H, Ebelt H, Zorn-Pauly
K, Koidl B, Hoke RS, Heinroth K and Müller-Werdan U: Impaired
regulation of cardiac function in sepsis, SIRS, and MODS. Can J
Physiol Pharmacol. 87:266–274. 2009. View
Article : Google Scholar : PubMed/NCBI
|
17
|
Zhou FJ, Zhou CY, Tian YJ, Xiao AJ, Li PL,
Wang YH and Jia JW: Diagnostic value of analysis of H-FABP,
NT-proBNP, and cTnI in heart function in children with congenital
heart disease and pneumonia. Eur Rev Med Pharmacol Sci.
18:1513–1516. 2014.PubMed/NCBI
|
18
|
Ding YJ, Han B, Yang B and Zhu M:
NT-proBNP plays an important role in the effect of ibuprofen on
preterm infants with patent ductus arteriosus. Eur Rev Med
Pharmacol Sci. 18:2596–2598. 2014.PubMed/NCBI
|
19
|
Russo A, Scagliusi A, Scarano A,
Bevilacqua F, Di Stasio E, Polidori L and Marana E: Influence of
pneumoperitoneum on left ventricular filling pressures and
NT-proBNP levels. Eur Rev Med Pharmacol Sci. 16:1570–1575.
2012.PubMed/NCBI
|
20
|
Kara S, Tonbul A, Karabel M, Akca H, Uras
N and Tatli M: The role of serum N-terminal pro-brain natriuretic
peptide in transient tachypnea of the newborn. Eur Rev Med
Pharmacol Sci. 17:1824–1829. 2013.PubMed/NCBI
|
21
|
Chen K, Jiang RJ, Wang CQ, Yin ZF, Fan YQ,
Cao JT, Han ZH, Wang Y and Song DQ: Predictive value of plasma
galectin-3 in patients with chronic heart failure. Eur Rev Med
Pharmacol Sci. 17:1005–1011. 2013.PubMed/NCBI
|
22
|
Shao N and Xie M: The impairment influence
of sepsis on myocardial mitochondria. China Med Her. 5:23–24.
2008.
|
23
|
Chagnon F, Bentourkia M, Lecomte R,
Lessard M and Lesur O: Endotoxin-induced heart dysfunction in rats:
assessment of myocardial perfusion and permeability and the role of
fluid resuscitation. Crit Care Med. 34:127–133. 2006. View Article : Google Scholar : PubMed/NCBI
|
24
|
Post F, Weilemann LS, Messow CM, Sinning C
and Münzel T: B-type natriuretic peptide as a marker for
sepsis-induced myocardial depression in intensive care patients.
Crit Care Med. 36:3030–3037. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ji X, Duan M and Li: Diagnostic value of
NT-PROBNP detection on pyemic myocardial damage. Mol Cardiol Chin.
207–209. 2010.
|
26
|
Xu R, Lu R, Jiang H, Li QF, Sun Y, Xu H
and Huang Y: Meta-analysis of protective effect of sevoflurane on
myocardium during cardiac surgery. Eur Rev Med Pharmacol Sci.
18:1058–1066. 2014.PubMed/NCBI
|
27
|
Casagranda I and Lauritano EC: Diagnostic
and prognostic significance of high sensitive troponin in chest
pain. Eur Rev Med Pharmacol Sci. 15:695–700. 2011.PubMed/NCBI
|
28
|
Charpentier J, Luyt C-E, Fulla Y,
Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP and Chiche
JD: Brain natriuretic peptide: A marker of myocardial dysfunction
and prognosis during severe sepsis. Crit Care Med. 32:660–665.
2004. View Article : Google Scholar : PubMed/NCBI
|
29
|
Li T, Liu JJ, Du WH, Wang X, Chen ZQ and
Zhang LC: 2D speckle tracking imaging to assess sepsis induced
early systolic myocardial dysfunction and its underlying
mechanisms. Eur Rev Med Pharmacol Sci. 18:3105–3114.
2014.PubMed/NCBI
|